TEOC Oncologia Clínica Practice Questions - TEOC - Título De Especialista Em Oncologia Clínica (Sociedade Brasileira De Oncologia Clínica AMB) Exam

Access More Questions

A 56-year-old postmenopausal woman undergoes breast-conserving surgery and axillary lymph node dissection for a 4.5 cm invasive ductal carcinoma. Pathology confirms ER 95%, PR 80%, HER2 1+ (negative), Ki-67 35%, and 5 out of 14 lymph nodes positive for macrometastases (pT2 pN2a cM0, Stage IIIA). She completes adjuvant dose-dense AC followed by paclitaxel and adjuvant radiotherapy. According to the monarchE phase III trial, which targeted agent should be added to her adjuvant endocrine therapy?

Palbociclib 125 mg daily (3 weeks on, 1 week off) for 2 years Abemaciclib 150 mg twice daily continuously for 2 years Ribociclib 600 mg daily (3 weeks on, 1 week off) for 3 years Everolimus 10 mg daily continuously for 1 year

Correct Answer:

Abemaciclib 150 mg twice daily continuously for 2 years

Access more questions from this quiz

Continue to TEOC Oncologia Clínica Practice Questions - TEOC - Título de Especialista em Oncologia Clínica (Sociedade Brasileira de Oncologia Clínica AMB) Exam for more practice questions and the full quiz experience.

Access More Questions